NCT06624865 Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors
| NCT ID | NCT06624865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hospices Civils de Lyon |
| Condition | Small-intestine Neuroendocrine Tumors |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-11-05 |
| Primary Completion | 2029-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2024-11-05 with a primary completion date of 2029-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to investigate the impact of the microenvironment on tumorigenesis of small intestinal neuroendocrine tumors often located in the terminal ileum, without identified driver mutations.
Eligibility Criteria
Inclusion Criteria: * Patient with one or more small-intestine neuroendocrine tumor with indication of surgery * Patient with consent for the collection, storage and reuse of data associated with his/her disease * Age ≥ 18 years at the time of inclusion * Non-objection statement obtained for participation in the study Exclusion Criteria: * Patients with poorly differentiated neuroendocrine carcinoma or NET (neuroendocrine tumors) of non-intestinal origin or mixed tumors (MiNEN) * Pregnant, parturient or breast-feeding women * Minors * Persons deprived of liberty by judicial or administrative decision * Adults under legal protection (guardianship, curatorship)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06624865 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Small-intestine Neuroendocrine Tumors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06624865 currently recruiting?
Yes, NCT06624865 is actively recruiting participants. Contact the research team at thomas.walter@chu-lyon.fr for enrollment information.
Where is the NCT06624865 trial being conducted?
This trial is being conducted at Lyon, France.
Who is sponsoring the NCT06624865 clinical trial?
NCT06624865 is sponsored by Hospices Civils de Lyon. The trial plans to enroll 75 participants.